Genevieve Almouzni
5Patents
1h-index
8Co-inventors
40Inventor score
Filing activity: Aug 28, 2006 → Sep 24, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10576103B2 | Immune cells defective for SUV39H1 | Chemistry; Metallurgy | 2 | Active |
| US7781174B2 | Proliferation markers in clinical practice and their use for cancer prognosis or diagnosis | Physics | 1 | Active |
| US11285176B2 | Immune cells defective for Suv39h1 | Chemistry; Metallurgy | 0 | Active |
| US12371471B2 | Immune cells defective for SUV39H1 | Chemistry; Metallurgy | 0 | Active |
| US11622978B2 | Immune cells defective for SUV39H1 | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.